To chart a path toward an equitable future, ASHG’s Board of Directors considered and approved in April 2021 an updated Diversity, Equity, and Inclusion Task Force Action Plan that recognizes a key strategic focus area, which is to acknowledge and reckon with a history of past harms linked to racism, eugenics, or other systemic forms... Read More
ASHG strives towards a world in which people everywhere realize the benefits of human genetics and genomics research. According to the ASHG public opinion survey released in 2020, while most of the public are curious and hopeful about genetics research, a portion is also cautious and there are still misunderstandings around basic genetic facts. As... Read More
The Society’s proposed language on diversity in research participation has been incorporated in the final version of this year’s Senate NIH funding bill. The proposed text included in the bill is below: The Committee recognizes the benefits of broad and inclusive participation in biomedical research for increasing health equity. Research cohorts of diverse genetic ancestry... Read More
ASHG remains committed to diversity, equity, and inclusion in genetics and genomics research. It is both a scientific and community imperative. Recognizing the importance of engagement and collaboration to accelerate this essential work, ASHG is excited to feature two National Institutes of Health senior leaders who have taken on the charge of advancing diversity, equity,... Read More
Diversity, equity, and inclusion are essential parts of ASHG’s mission, vision, and values. As a Board member and inaugural chair of the Diversity, Equity, and Inclusion (DEI) Task Force, I have experienced first-hand the growth and urgency of infusing DEI across our work within the Society and more broadly the genetics and genomics field. In... Read More